Abstract
Cannabinoids were found to augment phospholipase activities and modify lipid levels of mouse brain synaptosomes, myelin and mitochondria. Delta-1-tetrahydrocannabinol (Δ1-THC) and several of its metabolites induced a dose-dependent (0.32–16 μM) stimulation of phospholipase A2 (PLA2) activity resulting in the increased release of free arachidonic acid from exogenous [1-14C]phosphatidylcholine (PC). The potencies of the cannabinoids in modulating PLA2 activity were approximately of the order: 7-OH-Δ1-THC > Δ1-THC > 7-oxo-Δ1-THC > Δ1-THC-7oic acid = 6α OH-Δ1-THC ≫ 6β-OH-Δ1-THC. The hydrolysis of phosphatidylinositol (PI) by synaptosomal phospholipase C (PLC) was enhanced significantly by Δ1-THC and promoted diacylglyceride levels by greater than 100 percent compared to control values. In contrast, arachidonate was the major product resulting from phospholipase activities of a 20,000g pellet. Synaptosomal diacylglyceride lipase activity was inhibited by Δ1-THC. [1-14C]Arachidonic acid was readily incorporated into subcellular membrane phospholipids and after exposure to cannabinoids led to diminished phosphoglyceride levels and concomitant increases in released neutral lipid products. These data suggest that cannabinoids control phospholipid turnover and metabolism in mouse brain preparations by the activation of phospholipases and, through this mechanism, may exert some of their effects.
Similar content being viewed by others
References
Berridge, M. J., andIrvine, R. F. 1984. Inositol triphosphate, a novel second messenger in cellular signal transduction. Nature 312:315–321.
Blaustein, M. P., andGoldring, J. M. 1975. Membrane potentials in pinched-off presynaptic nerve terminals monitored with a fluorescent probe. J. Physiol. 247:589–615.
Burstein, S., andHunter, S. A. 1978. Release of arachidonic acid from HeLa cells by Δ1 tetrahydrocannabinol and other cannabinoids. Biochem. Pharmacol. 27:1275–1280.
Burstein, S., andHunter, S. A. 1981. Elevation of phospholipase A2 activity by cannabinoids in whole cells and subcellular preparations. J. Clin. Pharmacol. 21:240S-248S.
Burstein, S., andHunter, S. A. 1981. The Biochemistry of the Cannabinoids. Rev. in Pure and Applied Pharmacol. Sci. 2:155–226.
Burstein, S., Hunter, S. A., Sedor, C., andShulman, S. 1982. Stimulation of prostaglandin E2 synthesis in human lung fibroblasts by 1287-2. Biochem. Pharmacol. 31:2361–2365.
Burstein, S., Hunter, S. A., andOzman, K. 1983. The effect of cannabinoid structure on the synthesis of prostaglandins by human lung fibroblasts. Mol. Pharmacol. 23:121–126.
Burstein, S., Hunter, S. A., Ozman, K., andRenzulli, L. 1984. Cannabinoid-induced elevation of lipoxygenase products in mouse peritoneal macrophages. Biochem. Pharmacol. 33:2653–2656.
Burstein, S., Hunter, S. A., Ozman, K., andRenzulli, L. 1985. In vitro models of cannabinoid-induced psychoactivity. Pages 399–406,in Harvey, D. L. (ed.), Marihuana '84, Proceedings of the Oxford Symposium on Cannabis IRL Press, Ltd., Oxford.
Colburn, R. W., Ng., L. K. Y. Lemberger, L., andKopin, I. J. 1974. Subcellular distribution of Δ1-tetrahydrocannabinol in rat brain. Biochem. Pharmacol. 23:873–877.
Corbin, D. R., andSun, G. Y. 1978. Characterization of the enzymic transfer of arachidonyl groups tol-acyl-phosphoglycerides in mouse synaptosome fraction. J. Neurochem. 30:77–82.
Dawson, R. M. C., Hamington, N. L., andIrvine, R. F. 1983. Diacylglycerol potentiates phospholipase attack upon phospholipid bilayers: possible connection with cell stimulation. Biochem. Biophys. Res. Comm. 117:196–201.
Der, D. M., andSun, G. Y. 1981. Degradation of arachidonyl-labeled phosphatidylinositols by brain synaptosomes. J. Neurochem. 36:355–362.
Goracci, G., Porcellati, G., andWoelk, H. 1978. Subcellular localization and distribution of phospholipases A in liver and brain tissue. Adv. Prostaglandin Thromboxane Res. 3:55–67.
Harris, R. A., andStokes, J. A. 1982. Cannabinoids inhibit calcium uptake by brain synaptosomes. J. Neurosc. 2:443–447.
Hawthorne, J. N., andPickard, M. R. 1979. Phospholipids in synaptic fraction. J. Neurochem. 32:5–14.
Hillard, C. J., andBloom, A. S. 1984. Further studies of the interaction of Δ1-THC with the β-adrenergic receptor, Pages 591–602,in Agurell, S., Dewey, W. L., andWillete, R. E. (eds.), The Cannabinoids: Chemical, Pharmacologic, and Therapeutic AspectsAcademic Press, Orlando, FL.
Hunter, S. A., Burstein, S., andSedor, C. 1984. Stimulation of prostaglandin synthesis in WI-38 human lung fibroblasts following inhibition of phospholipid acylation by p-hydroxymercuribenzoate. Biochim. Biophys. Acta 793:202–212.
Hunter, S. A., Burstein, S., andRezulli, L. 1985. Cannabinoid modulated phospholipase activities by mouse brain subcellular fractions, Pages 245–252in Harvey, D. L. (eds.), Marihuana '84: Proceedings of the Oxford Symposium on Cannabis IRL Press, Ltd., Oxford.
Irvine, R. F. 1982. How is the level of free arachidonic acid controlled in mammalian cells? Biochem. J. 204:3–16.
Irvine, R. F., Hamington, N., andDawson, R. M. C. 1978. Hydrolysis of phosphatidylinositol by lysosomal enzymes of rat liver and brain. Biochem. J. 176:475–484.
Irvine, R. F., Letcher, A. J., andDawson, R. M. C. 1979. Fatty acid stimulation of membrane phosphatidylinositol hydrolysis by brain phosphatidylinositol phosphodiesterase. Biochem. J. 178:497–500.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., andRandall, R. J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265–275.
Mechoulam, R., McCallum, N. K., andBurstein, S. 1976. Recent advances in the chemistry and biochemistry of cannabis. Chemical Reviews 76:75–112.
Moskowitz, N., Puszkin, S., andShook, W. 1983. Characterization of brain synaptic vesicle phospholipase A2 activity and its modulation by calmodulin, prostaglandin E2, prostaglandin F2α, cyclic AMP and ATP. J. Neurochem. 41:1576–1586.
Nishizuki, Y. 1984. The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 308:693–698.
Oishi, R., Itoh, Y., Nishibori, M., andSaeki, K. 1984. 1288-1 decreases turnover of brain histamine. J. Pharmacol. Exp. Ther. 232:513–518.
Rittenhouse-Simmons, S. 1980. Indomethacin-induced accumulation of diglyceride in activated human platelets. J. Biol. Chem. 255:2259–2262.
Sanderman, G., Jr 1978. Regulation of membrane enzymes by lipids. Biochim. Biophys. Acta 515:209–237.
Schurr, A., andRigor, B. M. 1984. Cannabis extract, but not Δ1-tetrahydrocannabinol,inhibits human brain and liver monoamine oxidase. Gen. Pharmacol. 15:171–174.
Sun, A. Y., andSamorajski, T. 1970. Effects of ethanol on the activity of adenosine triphosphatase and acetylcholinesterase in synaptosomes isolated from guinea pig brain. J. Neurochem. 17:1365–1372.
Toro-Goyco, E. Rodriguez, M. B., Preston, A. M., andRosenthal, A. E. 1981. Cardiolipins are ‘in vitro’ inhibitors of rat brain (Na++K+)-dependent ATPases. Biochim. Biophys. Acta 642:96–105.
Wolfe, L. S. 1982. Eicosanoids: Prostaglandins, thromboxanes, leukotrienes, and other derivatives of carbon-20 unsaturated fatty acids. J. Neurochem. 38:1–14.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hunter, S.A., Burstein, S. & Renzulli, L. Effects of cannabinoids on the activities of mouse brain lipases. Neurochem Res 11, 1273–1288 (1986). https://doi.org/10.1007/BF00966122
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00966122